-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Silexion Therapeutics Corp quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q2 2023 to Q2 2025.
- Silexion Therapeutics Corp Net Cash Provided by (Used in) Investing Activities for the quarter ending June 30, 2025 was -$1K.
- Silexion Therapeutics Corp Net Cash Provided by (Used in) Investing Activities for the twelve months ending June 30, 2025 was -$23K.
- Silexion Therapeutics Corp annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$22K, a 104% decline from 2023.
Net Cash Provided by (Used in) Investing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)